159 related articles for article (PubMed ID: 9717158)
21. Role of gemifloxacin in community-acquired pneumonia.
Tillotson GS
Expert Rev Anti Infect Ther; 2008 Aug; 6(4):405-18. PubMed ID: 18662107
[TBL] [Abstract][Full Text] [Related]
22. Oral levofloxacin in the treatment of community-acquired pneumonia.
Nicodemo AC; Lima Nicodemo E; Idrahim KY
Braz J Infect Dis; 2000 Apr; 4(2):61-6. PubMed ID: 10795070
[TBL] [Abstract][Full Text] [Related]
23. [Empiric therapy of community-acquired pneumonia: a transatlantic controversy].
Garin N; Nendaz M
Rev Med Suisse; 2006 Jan; 2(50):289-90, 292-4. PubMed ID: 16503046
[TBL] [Abstract][Full Text] [Related]
24. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae.
Appelbaum PC
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S29-34. PubMed ID: 10984325
[TBL] [Abstract][Full Text] [Related]
25. Pneumonia in children.
Berti I; Faraguna D
N Engl J Med; 2002 Jun; 346(24):1916; author reply 1916. PubMed ID: 12063383
[No Abstract] [Full Text] [Related]
26. Sparfloxacin empirical therapy in community-acquired pneumonia. Results of a meta-analysis of 2 comparative studies.
Grassi GG; Brumpt I
Drugs; 1995; 49 Suppl 2():406-8. PubMed ID: 8549379
[No Abstract] [Full Text] [Related]
27. The role of fluoroquinolones in respiratory tract infections: community acquired pneumonia.
García-Rodríguez JA; Muñoz Bellido JL
Int J Antimicrob Agents; 2000 Nov; 16(3):281-5. PubMed ID: 11091048
[TBL] [Abstract][Full Text] [Related]
28. New antibiotic approved for community-acquired infections.
Nurse Pract; 1998 Jan; 23(1):94. PubMed ID: 9470200
[No Abstract] [Full Text] [Related]
29. [Quinolones and Streptococcus pneumoniae. Mechanisms of action and resistance].
Taléns-Visconti R; Garrigues TM; Cantón E
Rev Esp Quimioter; 2002 Dec; 15(4):313-24. PubMed ID: 12587036
[TBL] [Abstract][Full Text] [Related]
30. Challenges in the management of community-acquired pneumonia: the role of quinolones and moxifloxacin.
Niederman MS
Clin Infect Dis; 2005 Jul; 41 Suppl 2():S158-66. PubMed ID: 15942882
[TBL] [Abstract][Full Text] [Related]
31. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
Jones RN; Sader HS; Stilwell MG; Fritsche TR
Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
[TBL] [Abstract][Full Text] [Related]
32. Novel agents for the treatment of outpatient respiratory tract infections. Introduction.
Pell DM
Postgrad Med; 2002 Sep; 112(3 Suppl):5-6. PubMed ID: 19667592
[No Abstract] [Full Text] [Related]
33. Fluoroquinolones for respiratory infections: too valuable to overuse.
Williams JH
Chest; 2001 Dec; 120(6):1771-5. PubMed ID: 11742900
[No Abstract] [Full Text] [Related]
34. Community-acquired pneumonia.
Holmes A; Jacklin A; Impallomeni M; Rogers TR
Lancet; 1999 May; 353(9163):1528-9. PubMed ID: 10232345
[No Abstract] [Full Text] [Related]
35. [Accordance to guidelines for community acquired pneumonia in Europe and in the world].
Giejło M; Szmidt M
Pneumonol Alergol Pol; 2007; 75(2):173-9. PubMed ID: 17973225
[TBL] [Abstract][Full Text] [Related]
36. Fluoroquinolones for respiratory infection: too valuable to overuse (and too valuable to misuse!).
Weiss K; Tillotson GS
Chest; 2002 Sep; 122(3):1102-3; author reply 1103. PubMed ID: 12226065
[No Abstract] [Full Text] [Related]
37. [Pharmacodynamic and pharmacokinetic approaches to optimization of lomefloxacin].
Iakovlev SV
Antibiot Khimioter; 1998; 43(10):42-5. PubMed ID: 9825110
[No Abstract] [Full Text] [Related]
38. Journal of Managed Care Pharmacy. START (Stewardship Tactics for Antimicrobial Resistance Trends). Introduction.
Rodvold KA
J Manag Care Pharm; 2009 Mar; 15(2 Suppl):S3-4. PubMed ID: 19358369
[No Abstract] [Full Text] [Related]
39. Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae.
Hammerschlag MR; Roblin PM
Antimicrob Agents Chemother; 2000 May; 44(5):1409. PubMed ID: 10819727
[No Abstract] [Full Text] [Related]
40. [New quinolones].
Kakeya H; Fukushima K; Saito A
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():542-8. PubMed ID: 17455678
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
